vs

Side-by-side financial comparison of CRA INTERNATIONAL, INC. (CRAI) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.

LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $197.0M, roughly 1.9× CRA INTERNATIONAL, INC.). CRA INTERNATIONAL, INC. runs the higher net margin — 6.7% vs 3.1%, a 3.6% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 11.6%). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 7.1%).

CRA International, Inc. is a global consulting firm headquartered in Boston. The firm provides expert testimony and litigation support, strategic advice, and analysis to law firms, corporations, accounting firms, and governments.

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

CRAI vs LFST — Head-to-Head

Bigger by revenue
LFST
LFST
1.9× larger
LFST
$382.2M
$197.0M
CRAI
Growing faster (revenue YoY)
LFST
LFST
+5.8% gap
LFST
17.4%
11.6%
CRAI
Higher net margin
CRAI
CRAI
3.6% more per $
CRAI
6.7%
3.1%
LFST
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
7.1%
CRAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CRAI
CRAI
LFST
LFST
Revenue
$197.0M
$382.2M
Net Profit
$13.2M
$11.7M
Gross Margin
Operating Margin
10.5%
4.7%
Net Margin
6.7%
3.1%
Revenue YoY
11.6%
17.4%
Net Profit YoY
-12.0%
264.1%
EPS (diluted)
$1.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRAI
CRAI
LFST
LFST
Q4 25
$197.0M
$382.2M
Q3 25
$185.9M
$363.8M
Q2 25
$186.9M
$345.3M
Q1 25
$181.9M
$333.0M
Q4 24
$176.4M
$325.5M
Q3 24
$167.7M
$312.7M
Q2 24
$171.4M
$312.3M
Q1 24
$171.8M
$300.4M
Net Profit
CRAI
CRAI
LFST
LFST
Q4 25
$13.2M
$11.7M
Q3 25
$11.5M
$1.1M
Q2 25
$12.1M
$-3.8M
Q1 25
$18.0M
$709.0K
Q4 24
$15.0M
$-7.1M
Q3 24
$11.4M
$-6.0M
Q2 24
$6.5M
$-23.3M
Q1 24
$13.7M
$-21.1M
Operating Margin
CRAI
CRAI
LFST
LFST
Q4 25
10.5%
4.7%
Q3 25
9.3%
2.0%
Q2 25
10.6%
-0.9%
Q1 25
14.0%
0.5%
Q4 24
12.2%
0.3%
Q3 24
11.0%
0.0%
Q2 24
6.6%
-5.1%
Q1 24
11.4%
-5.6%
Net Margin
CRAI
CRAI
LFST
LFST
Q4 25
6.7%
3.1%
Q3 25
6.2%
0.3%
Q2 25
6.5%
-1.1%
Q1 25
9.9%
0.2%
Q4 24
8.5%
-2.2%
Q3 24
6.8%
-1.9%
Q2 24
3.8%
-7.5%
Q1 24
8.0%
-7.0%
EPS (diluted)
CRAI
CRAI
LFST
LFST
Q4 25
$1.99
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRAI
CRAI
LFST
LFST
Cash + ST InvestmentsLiquidity on hand
$18.2M
$248.6M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$213.6M
$1.5B
Total Assets
$628.9M
$2.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRAI
CRAI
LFST
LFST
Q4 25
$18.2M
$248.6M
Q3 25
$22.5M
$203.9M
Q2 25
$19.4M
$188.9M
Q1 25
$25.6M
$134.3M
Q4 24
$26.7M
$154.6M
Q3 24
$24.5M
$102.6M
Q2 24
$24.6M
$87.0M
Q1 24
$37.1M
$49.5M
Total Debt
CRAI
CRAI
LFST
LFST
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
CRAI
CRAI
LFST
LFST
Q4 25
$213.6M
$1.5B
Q3 25
$201.7M
$1.5B
Q2 25
$197.0M
$1.5B
Q1 25
$227.3M
$1.5B
Q4 24
$212.1M
$1.4B
Q3 24
$204.5M
$1.4B
Q2 24
$191.7M
$1.4B
Q1 24
$211.8M
$1.4B
Total Assets
CRAI
CRAI
LFST
LFST
Q4 25
$628.9M
$2.2B
Q3 25
$629.0M
$2.1B
Q2 25
$606.8M
$2.1B
Q1 25
$590.4M
$2.1B
Q4 24
$571.4M
$2.1B
Q3 24
$582.3M
$2.1B
Q2 24
$546.0M
$2.1B
Q1 24
$552.5M
$2.1B
Debt / Equity
CRAI
CRAI
LFST
LFST
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRAI
CRAI
LFST
LFST
Operating Cash FlowLast quarter
$22.4M
$57.6M
Free Cash FlowOCF − Capex
$46.6M
FCF MarginFCF / Revenue
12.2%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
1.70×
4.93×
TTM Free Cash FlowTrailing 4 quarters
$110.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRAI
CRAI
LFST
LFST
Q4 25
$22.4M
$57.6M
Q3 25
$36.5M
$27.3M
Q2 25
$5.9M
$64.4M
Q1 25
$-80.0M
$-3.1M
Q4 24
$79.4M
$62.3M
Q3 24
$31.6M
$22.7M
Q2 24
$1.8M
$44.1M
Q1 24
$-63.1M
$-21.8M
Free Cash Flow
CRAI
CRAI
LFST
LFST
Q4 25
$46.6M
Q3 25
$35.9M
$17.0M
Q2 25
$4.7M
$56.6M
Q1 25
$-81.0M
$-10.3M
Q4 24
$68.8M
$56.0M
Q3 24
$28.6M
$17.7M
Q2 24
$-509.0K
$39.0M
Q1 24
$-63.8M
$-26.9M
FCF Margin
CRAI
CRAI
LFST
LFST
Q4 25
12.2%
Q3 25
19.3%
4.7%
Q2 25
2.5%
16.4%
Q1 25
-44.5%
-3.1%
Q4 24
39.0%
17.2%
Q3 24
17.0%
5.7%
Q2 24
-0.3%
12.5%
Q1 24
-37.1%
-9.0%
Capex Intensity
CRAI
CRAI
LFST
LFST
Q4 25
2.9%
Q3 25
0.3%
2.8%
Q2 25
0.6%
2.2%
Q1 25
0.5%
2.2%
Q4 24
6.0%
1.9%
Q3 24
1.8%
1.6%
Q2 24
1.4%
1.6%
Q1 24
0.4%
1.7%
Cash Conversion
CRAI
CRAI
LFST
LFST
Q4 25
1.70×
4.93×
Q3 25
3.19×
25.34×
Q2 25
0.48×
Q1 25
-4.44×
-4.36×
Q4 24
5.30×
Q3 24
2.76×
Q2 24
0.28×
Q1 24
-4.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons